Cargando…
The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
Recently, new but expensive treatments have become available for metastatic melanoma. These improve survival, but in view of the limited funds available, cost-effectiveness needs to be evaluated. Most cancer cost-effectiveness models are based on the observed clinical events such as recurrence- free...
Autores principales: | van der Meijde, Elisabeth, van den Eertwegh, Alfons J. M., Linn, Sabine C., Meijer, Gerrit A., Fijneman, Remond J. A., Coupé, Veerle M. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912231/ https://www.ncbi.nlm.nih.gov/pubmed/27346945 http://dx.doi.org/10.4137/CIN.S38122 |
Ejemplares similares
-
Extent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy
por: Turksma, Annelies, et al.
Publicado: (2015) -
KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
por: Uil, Sjoerd H., et al.
Publicado: (2022) -
MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018) -
Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
por: den Uil, Sjoerd H., et al.
Publicado: (2019) -
Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)